The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 05, 2024

Filed:

Oct. 30, 2015
Applicants:

Kyoto Prefectural Public University Corporation, Kyoto, JP;

The Doshisha, Kyoto, JP;

Senju Pharmaceutical Co., Ltd., Osaka, JP;

Inventors:

Noriko Koizumi, Kyotanabe, JP;

Naoki Okumura, Kyotanabe, JP;

Shigeru Kinoshita, Kyoto, JP;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 38/39 (2006.01); A61K 9/00 (2006.01); A61K 31/4409 (2006.01); A61K 35/30 (2015.01); A61K 45/00 (2006.01); A61K 45/06 (2006.01); A61P 27/02 (2006.01);
U.S. Cl.
CPC ...
A61K 38/39 (2013.01); A61K 9/0048 (2013.01); A61K 31/4409 (2013.01); A61K 35/30 (2013.01); A61K 45/00 (2013.01); A61K 45/06 (2013.01); A61P 27/02 (2018.01);
Abstract

The present invention provides a technique for treating retinal epithelium and/or nerves. More specifically, the present invention is an agent for the treatment or prevention of retinal disease or the like and/or a disease, disorder, or ophthalmological state of the nerves, the agent including at least one factor selected from the group consisting of laminin and fragments thereof, wherein the problem is solved by also providing a technique characterized in that this agent is administered together with retinal pigment epithelial cells and/or nerve cells. Specifically, the present invention can include laminin 411 (α4β1γ1), laminin 511 (α5β1γ1), laminin 521 (α5β2γ1), or fragments of these.


Find Patent Forward Citations

Loading…